Showing 1 - 10 of 16
Persistent link: https://www.econbiz.de/10000672114
Persistent link: https://www.econbiz.de/10011519891
.0 percent of world population, implying 150 million deaths when applied to current population. Regressions with annual …
Persistent link: https://www.econbiz.de/10012839262
This paper argues that openness to goods trade in combination with an unequal distribution of political power has been a major determinant of the comparatively slow development of resource- or land-abundant regions like South America and the Caribbean in the nineteenth century. We develop a...
Persistent link: https://www.econbiz.de/10010261261
This paper examines the impact of capital market integration (CMI) on higher education and economic growth. We take into account that participation in higher education is noncompulsory and depends on individual choice. Integration increases (decreases) the incentives to participate in higher...
Persistent link: https://www.econbiz.de/10010261393
We discuss public pension systems in a multi-period overlapping generations model with gerontologically founded human aging and a special focus on occupation-specific morbidity and mortality. We examine how distinct replacement rates for white-collar and blue-collar workers and early retirement...
Persistent link: https://www.econbiz.de/10013219069
The theory of endogenous technical change has deeply contributed to our understanding of the fundamental sources of …
Persistent link: https://www.econbiz.de/10010264065
Incumbent firms have two basic possibilities to improve their competitive position in the product market: investment in R&D and the creation of entry barriers to the disadvantage of potential rivals, e.g. through lobbying activities, campaign contributions, bribes or the adoption of incompatible...
Persistent link: https://www.econbiz.de/10010264105
R&D-based growth theory suggests that a larger population size raises either the long-run rate of economic growth …
Persistent link: https://www.econbiz.de/10010264334
This paper examines the role of both cost-sharing schemes in health insurance systems and entry regulation for pharmaceutical R&D expenditure, drug prices, aggregate productivity, and income. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations...
Persistent link: https://www.econbiz.de/10010275019